Gyre Therapeutics (GYRE) Revenue Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 2.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.09% |
| Dec 31, 2025 | 33.45% |
| Sep 30, 2025 | 19.92% |
| Jun 30, 2025 | 6.13% |
| Mar 31, 2025 | -18.82% |
| Dec 31, 2024 | 2.67% |
| Sep 30, 2024 | -20.45% |
| Jun 30, 2024 | -13.99% |
| Mar 31, 2024 | 8.99% |
| Dec 31, 2023 | -73.25% |
| Mar 31, 2023 | 3,039.92% |
| Dec 31, 2022 | 4,059.67% |
| Mar 31, 2022 | -45.88% |
| Dec 31, 2021 | 20.14% |
| Sep 30, 2021 | 157.45% |
| Jun 30, 2021 | -31.72% |
| Mar 31, 2021 | -91.04% |
| Mar 31, 2018 | -97.79% |
| Dec 31, 2017 | 347.89% |
| Sep 30, 2017 | 191.74% |
| Jun 30, 2017 | 1.83% |
| Mar 31, 2017 | 148.62% |
| Dec 31, 2016 | -34.86% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | -87.31% |
| Mar 31, 2016 | -83.78% |
| Dec 31, 2015 | -83.78% |
| Sep 30, 2015 | -80.07% |
| Jun 30, 2015 | 189.23% |
| Mar 31, 2015 | 126.26% |
| Dec 31, 2014 | 622.58% |
| Mar 31, 2014 | -91.60% |
| Dec 31, 2013 | -84.24% |
| Mar 31, 2013 | -84.53% |
| Dec 31, 2012 | -96.89% |
| Sep 30, 2012 | -95.95% |
| Jun 30, 2012 | 62.20% |
| Mar 31, 2012 | -41.38% |
| Dec 31, 2011 | -13.59% |
| Sep 30, 2011 | 13,837.50% |
| Jun 30, 2011 | 10,376.26% |